Palencia R, Cilleruelo M L, Tresierra F, Blanco A
An Esp Pediatr. 1983 Feb;18(2):103-6.
The authors analyze the value of phenobarbital for prophylaxis of new convulsions in a group of 370 patients who had previously had febrile seizures. Percentage of recurrences in phenobarbital treated cases (4 +/- 0,6 mg/Kg/d) was 18,67%, versus 55,89% in untreated children (p less than 0.001). The presence of family history of epileptic or febrile seizures is a risk factor (p less than 0.01) that facilitates failure of phenobarbital prophilaxis in future febrile seizures.
作者分析了苯巴比妥对一组370例既往有热性惊厥患者预防新惊厥发作的价值。接受苯巴比妥治疗的病例(4±0.6mg/Kg/天)复发率为18.67%,而未治疗儿童的复发率为55.89%(p<0.001)。癫痫或热性惊厥家族史的存在是一个危险因素(p<0.01),会促使苯巴比妥预防未来热性惊厥失败。